Abaloparatide Real‐World Patient Experience Study

Results From a Patient Experience Study in Pediatric Gastrointestinal Endoscopy

OBJECTIVE Gastrointestinal endoscopy in children has become a standard diagnostic and therapeutic modality. The aim of our study was to characterize the most memorable elements of the patient experience from the parent's and patient's perspective and determine ways to improve the overall quality of their experience. METHODS Using a structured questionnaire, we conducted 47 phone interviews wi...

Psychiatric assessment of mood instability: qualitative study of patient experience.

BACKGROUND Mood instability is a common reason for psychiatric referral. Very little is known about how patients with unstable mood experience assessment and diagnosis. AIMS To investigate the experiences of assessment and diagnosis among patients with mood instability and to suggest improvements to this process. METHOD Qualitative study, gathering data through individual interviews with 28...

Defining Patient Experience

In recent years, perceptions of performance and quality of healthcare organizations have begun to move beyond examining the provision of excellent clinical care, alone, and to consider and embrace the patient experience as an important indicator. There is a need to determine the extent to which clear and formal definitions exist, have common overarching themes, and/or have unique, but important...

Patient experience of overtreatment.

Abaloparatide: a new anabolic therapy on the horizon.

Teriparatide administered by daily subcutaneous injection, was approved in the United States in 2002, and has been the only anabolic medication available in the United States for almost 13 years. Outside the US, teriparatide is joined only by intact PTH (1–84) as anabolic therapy for osteoporosis treatment. Although both anabolic and antiresorptive medications improve bone density and strength,...